Multilateral development banks (MDBs) are moving to centre stage in global health financing, driven by collapsing bilateral aid and political momentum from initiatives like the Accra Reset. Experts view the shift as an opportunity to deliver the predictable, large-scale investment needed to strengthen domestic health systems – provided governments and lenders can ensure transparent terms […] Continue reading ->
WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence  “within three to four weeks” – as soon as  DRC regulators issue their own approval,  said WHO’s Science Director Meg Doherty, at a Wednesday […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV, developed by Dr Reddy’s Laboratories based in India. Dr Reddy’s was one of six pharmaceutical manufacturers that was granted a non-exclusive, royalty-free voluntary licensing agreement from Gilead, which developed lenacapavir. The agreement, […] Continue reading ->
The World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), its highest alarm level, twice within two years, in 2022 and 2024. But “preventable health emergencies are a sign of failure”, said Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response. “They happen when community health care […] Continue reading ->
Former Global Fund executive director Mark Dybul returns to the helm in Geneva, facing an unprecedented $5.32 billion funding gap, fraught domestic transitions, and mounting demands to overhaul the global health architecture. While experts welcome his track record, balancing transatlantic rivalries with rising country sovereignty will demand delicate diplomacy and an updated playbook. The board […] Continue reading ->